More importantly, they identified specific macrophage subpopulations that are critical for resolving MASH and liver fibrosis in which accumulating scar tissue impairs the organ's ability to ...

Macrophages are also being developed to help battle a range of other diseases, including fibrosis of the lung and liver, as well as inflammatory diseases such as arthritis and asthma. Clinical ...

The liver is a vital organ, crucial to digestion, metabolism and the elimination of toxins. It has a unique ability, ...

PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced a revised operating plan as it evaluates a range of ...

After a year of stripping back its head count and pipeline, Carisma Therapeutics is now cutting down to the bone and laying ...

D. Boral Capital lowered the firm’s price target on Carisma Therapeutics (CARM) to $1 from $12 and keeps a Buy rating on the shares after the ...

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral hepatitis, alcohol-related liver disease, and non-alcoholic fatty liver ...

Although macrophages, a type of immune cell ... In addition to pulmonary fibrosis, YAP and TAZ are also implicated in heart, liver and kidney fibrosis, suggesting that therapies targeting these ...